Clinical Trial Update: Gingivitis Reduction After Use of 0.45% Stannous Fluoride Toothpaste [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating gingivitis reduction with 0.45% stannous fluoride toothpaste completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingivitis
• Plaque Dental

Drugs mentioned

• 0.45% Stannous fluoride toothpaste (stannous fluoride)

Snippet

Sponsor: Colgate Palmolive | Conditions: Gingivitis, Plaque, Dental | Phase 3 | Status: COMPLETED